Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

Bioque, M. ; García-Portilla, M.A.P. ; García-Rizo, C. ; Cabrera, B. ; Lobo, A. (Universidad de Zaragoza) ; González-Pinto, A. ; Díaz-Caneja, C.M. ; Corripio, I. ; Vieta, E. ; Castro-Fornieles, J. ; Bobes, J. ; Gutiérrez-Fraile, M. ; Rodriguez-Jimenez, R. ; Mezquida, G. ; Llerena, A. ; Saiz-Ruiz, J. ; Bernardo, M. ; PEPs, GROUP

Resumen: Patients with a first episode of psychosis (FEP) display a broad range of metabolic risk factors related to the development of diverse medical comorbidities. Initial stages of these disorders are essential in understanding the increased vulnerability of developing cardiometabolic disturbances, associated with a reduced life expectancy. This study aimed to evaluate the metabolic profile of a cohort of patients with a FEP and its evolution during a two year follow-up, as well as the factors that influence the changes in their metabolic status. 16 participating centers from the PEPs Project recruited 335 subjects with a FEP and 253 matched healthy controls, aged 9–35 years. We investigated a set of anthropometric measures, vital signs and laboratory data obtained from each participant over two years in a prospective, naturalistic study. From the beginning of the study the FEP group showed differences in the metabolic profile compared to the control group, together with a progressive worsening in the major part of the analyzed variables during the follow-up period, with higher rates of obesity and metabolic syndrome. Certain risk factors were related to determinate clinical variables such as male gender, the presence of affective symptoms or an early onset or to treatment variables such as the use of antipsychotic polypharmacy, antidepressants or mood stabilizers. Our results highlight the extremely high risk of patients at early phases of schizophrenia and other psychotic disorders of developing cardiovascular comorbidity and the fast worsening of the metabolic profile during the first two years.

Idioma: Inglés

DOI: 10.1016/j.schres.2017.06.032

Año: 2018

Publicado en: SCHIZOPHRENIA RESEARCH 193 (2018), 188-196
ISSN: 0920-9964

Factor impacto JCR: 4.569 (2018)

Categ. JCR: PSYCHIATRY rank: 19 / 142 = 0.134 (2018) - Q1 - T1
Categ. JCR: PSYCHIATRY rank: 25 / 146 = 0.171 (2018) - Q1 - T1

Factor impacto SCIMAGO: 2.168 - Psychiatry and Mental Health (Q1) - Biological Psychiatry (Q1)

Financiación: info:eu-repo/grantAgreement/ES/FEDER/Una manera de hacer Europa
Financiación: info:eu-repo/grantAgreement/ES/MINECO-ISCIII/PI-080208-PEPs study

Tipo y forma: Article (PostPrint)

Área (Departamento): Area Psiquiatría (Dpto. Medicina, Psiqu. y Derm.)